(Q33215197)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15897913%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

title

Inhibiting angiogenesis and tumorigenesis by a synthetic molecule that blocks binding of both VEGF and PDGF to their receptors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15897913%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15897913%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Laura Baldini

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15897913%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Luca Baldini

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15897913%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

author name string

Jiazhi Sun

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15897913%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

De-An Wang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15897913%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Rishi K Jain

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15897913%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Steve Paquette

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15897913%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Eileen Ennis

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15897913%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Michelle A Blaskovich

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15897913%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Domenico Coppola

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15897913%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Andrew D Hamilton

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15897913%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Saïd M Sebti

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15897913%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

language of work or name

English

0 references

publication date

1 July 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15897913%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15897913%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15897913%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

issue

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15897913%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

page(s)

4701-4709

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15897913%20AND%20SRC:MED&resulttype=core&format=json

Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors

11 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208391

Regression of established tumors and metastases by potent vascular endothelial growth factor blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208391

Involvement of loop 2 of platelet-derived growth factor-AA and -BB in receptor binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208391

7 January 2021

Angiogenesis in cancer and other diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208391

7 January 2021

VEGF and the quest for tumour angiogenesis factors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208391

7 January 2021

Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208391

7 January 2021

Tumor angiogenesis: past, present and the near future

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208391

7 January 2021

Kallistatin is a new inhibitor of angiogenesis and tumor growth

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208391

7 January 2021

From oncogene to drug: development of small molecule tyrosine kinase inhibitors as anti-tumor and anti-angiogenic agents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208391

7 January 2021

HARP induces angiogenesis in vivo and in vitro: implication of N or C terminal peptides

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208391

7 January 2021

Inhibition of angiogenesis by Abeta peptides

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208391

7 January 2021

Vascular-specific growth factors and blood vessel formation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208391

7 January 2021

A monoclonal antibody that blocks VEGF binding to VEGFR2 (KDR/Flk-1) inhibits vascular expression of Flk-1 and tumor growth in an orthotopic human breast cancer model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208391

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1208391

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15897913%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

11 January 2020

1044081180

0 references

1 reference